UnitedHealth Group Incorporated (NYSE:UNH) Director Richard T. Burke sold 15,000 shares of the company’s stock in a transaction dated Monday, August 21st. The shares were sold at an average price of $191.71, for a total transaction of $2,875,650.00. Following the completion of the transaction, the director now directly owns 1,818,898 shares of the company’s stock, valued at $348,700,935.58. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink.

Shares of UnitedHealth Group Incorporated (NYSE:UNH) traded up 1.44% during midday trading on Tuesday, hitting $194.79. 2,021,757 shares of the company’s stock traded hands. UnitedHealth Group Incorporated has a 1-year low of $132.39 and a 1-year high of $196.04. The company has a 50 day moving average price of $190.68 and a 200 day moving average price of $176.29. The firm has a market capitalization of $188.33 billion, a price-to-earnings ratio of 23.40 and a beta of 0.64.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Tuesday, July 18th. The healthcare conglomerate reported $2.46 earnings per share for the quarter, beating the consensus estimate of $2.38 by $0.08. The business had revenue of $50.05 billion for the quarter, compared to analyst estimates of $49.97 billion. UnitedHealth Group had a net margin of 4.32% and a return on equity of 21.52%. The firm’s revenue was up 7.7% on a year-over-year basis. During the same period in the previous year, the business earned $1.96 EPS. Equities analysts anticipate that UnitedHealth Group Incorporated will post $9.87 earnings per share for the current year.

The company also recently declared a quarterly dividend, which will be paid on Tuesday, September 19th. Shareholders of record on Friday, September 8th will be given a $0.75 dividend. The ex-dividend date of this dividend is Thursday, September 7th. This represents a $3.00 dividend on an annualized basis and a yield of 1.54%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 35.13%.

TRADEMARK VIOLATION NOTICE: “UnitedHealth Group Incorporated (UNH) Director Sells $2,875,650.00 in Stock” was posted by American Banking News and is the property of of American Banking News. If you are accessing this news story on another domain, it was copied illegally and republished in violation of U.S. and international copyright & trademark legislation. The correct version of this news story can be accessed at https://www.americanbankingnews.com/2017/08/22/unitedhealth-group-incorporated-unh-director-sells-2875650-00-in-stock.html.

A number of research firms have weighed in on UNH. Jefferies Group LLC reissued a “buy” rating and issued a $215.00 price objective on shares of UnitedHealth Group in a research report on Friday. Morgan Stanley upped their price objective on shares of UnitedHealth Group from $210.00 to $215.00 and gave the company an “overweight” rating in a research report on Thursday, August 17th. Cowen and Company reissued an “outperform” rating and issued a $220.00 price objective (up from $175.00) on shares of UnitedHealth Group in a research report on Friday, August 11th. Zacks Investment Research raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $215.00 price objective for the company in a research report on Tuesday, August 1st. Finally, Oppenheimer Holdings, Inc. reissued an “outperform” rating and issued a $205.00 price objective (up from $203.00) on shares of UnitedHealth Group in a research report on Friday, July 21st. One analyst has rated the stock with a hold rating and twenty-four have issued a buy rating to the company. The company presently has an average rating of “Buy” and an average price target of $203.41.

Institutional investors have recently added to or reduced their stakes in the stock. Patriot Financial Group Insurance Agency LLC raised its position in UnitedHealth Group by 1,722.9% in the first quarter. Patriot Financial Group Insurance Agency LLC now owns 638 shares of the healthcare conglomerate’s stock worth $106,000 after buying an additional 603 shares during the period. Blue Chip Partners Inc. purchased a new position in UnitedHealth Group during the second quarter worth approximately $110,000. Cribstone Capital Management LLC raised its position in UnitedHealth Group by 22.6% in the first quarter. Cribstone Capital Management LLC now owns 678 shares of the healthcare conglomerate’s stock worth $113,000 after buying an additional 125 shares during the period. Kings Point Capital Management raised its position in UnitedHealth Group by 27.9% in the first quarter. Kings Point Capital Management now owns 687 shares of the healthcare conglomerate’s stock worth $113,000 after buying an additional 150 shares during the period. Finally, Bruderman Asset Management LLC purchased a new position in UnitedHealth Group during the second quarter worth approximately $114,000. Hedge funds and other institutional investors own 86.21% of the company’s stock.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Insider Buying and Selling by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related companies with MarketBeat.com's FREE daily email newsletter.